, Cancer of the Ovary, New England Journal of Medicine, vol.351, issue.24, pp.2519-2548, 2004.
DOI : 10.1056/NEJMra041842
, Ovarian cancer: incidence and mortality in France], J Gynecol Obstet Biol Reprod (Paris), vol.34, pp.154-61, 2005.
, Management of Platinum-Sensitive Recurrent Ovarian Cancer, Seminars in Oncology, vol.33, pp.12-18, 2006.
DOI : 10.1053/j.seminoncol.2006.03.012
, Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment, The Lancet Oncology, vol.10, issue.1, pp.72-81, 2009.
DOI : 10.1016/S1470-2045(08)70335-8
, Heregulin-mediated ErbB2-ERK Signaling Activates Hyaluronan Synthases Leading to CD44-dependent Ovarian Tumor Cell Growth and Migration, Journal of Biological Chemistry, vol.282, issue.27, 2007.
DOI : 10.1074/jbc.M610054200
, Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12, International Journal of Cancer, vol.128, pp.715-740, 2011.
, Oncologic trogocytosis of 23, Spaeth EL, Dembinski JL
, Mesenchymal Stem Cell Transition to Tumor?Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression, PLoS ONE Pasquet M, Golzio M, vol.4, pp.4992-5016, 2009.
, Hospicells (ascites?derived stromal cells) promote tumorigenicity and angiogenesis, International Journal of Cancer, vol.126, pp.2090-101, 2010.
, Human ovarian carcinoma?associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production, The Journal of Clinical Investigation, vol.121, pp.3206-3225, 2011.
, CCL18 from tumor?associated macrophages promotes breast cancer metastasis via PITPNM3 Tumor metastasis: molecular insights and evolving paradigms Expression of soluble interleukin?6 receptor in malignant ovarian tissue, Cancer Cell Cell Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell Am J Obstet Gynecol, vol.19147140203, issue.28, pp.541-55, 2010.
, Cross talk of signals between EGFR and IL?6R through JAK2/STAT3 mediate epithelial?mesenchymal transition in ovarian carcinomas, Br J Cancer, vol.100, pp.134-178, 2009.
, Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast, Cell, vol.145, pp.926-966, 2011.
, Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks, Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks, pp.614-638
DOI : 10.1158/0008-5472.CAN-10-0538
URL : https://hal.archives-ouvertes.fr/hal-01431944
, Cancer Statistics, 2009, CA: A Cancer Journal for Clinicians, vol.59, issue.4, pp.225-274, 2009.
DOI : 10.3322/caac.20006
, Diagnosis and Management of Epithelial Ovarian Cancer, Obstetrics & Gynecology, vol.107, issue.6, pp.1399-410, 2006.
DOI : 10.1097/01.AOG.0000220516.34053.48
, ???Optimal??? cytoreduction for advanced epithelial ovarian cancer: A commentary, Gynecologic Oncology, vol.103, issue.1, pp.329-364, 2006.
DOI : 10.1016/j.ygyno.2006.07.004
, Management of Platinum-Sensitive Recurrent Ovarian Cancer, Seminars in Oncology, vol.33, pp.12-16, 2006.
DOI : 10.1053/j.seminoncol.2006.03.012
, Cancer cell adaptation to chemotherapy, BMC Cancer, vol.299, issue.2, p.78, 2005.
DOI : 10.1074/jbc.M211093200
, Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer, New England Journal of Medicine, vol.354, issue.1, pp.34-43, 2006.
DOI : 10.1056/NEJMoa052985
, Survival After Second-Line Intraperitoneal Therapy for the Treatment of Epithelial Ovarian Cancer, International Journal of Gynecological Cancer, vol.8, issue.2, pp.223-232, 2009.
DOI : 10.1111/IGC.0b013e31819bdc7e
, Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement, Annals of Surgical Oncology, vol.12, issue.1, pp.128-161, 2007.
DOI : 10.1245/s10434-006-9185-7
, Hyperthermia in combined treatment of cancer, The Lancet Oncology, vol.3, issue.8, pp.487-97, 2002.
DOI : 10.1016/S1470-2045(02)00818-5
, A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma, Cancer, vol.5, issue.2, pp.277-82, 2003.
DOI : 10.1002/cncr.11475
, Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II)
, Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin???DNA adduct formation in patients and ovarian cancer cell lines, European Journal of Cancer, vol.34, issue.1, pp.1136-1175, 1980.
DOI : 10.1016/S0959-8049(97)00370-5
, C): Cell killing and molecular events, International Journal of Hyperthermia, vol.267, issue.1, pp.3-15, 2009.
DOI : 10.1158/0008-5472.CAN-04-1876
, Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery, Cancer, vol.27, issue.5, pp.884-91, 1997.
DOI : 10.1002/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C
, Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity, International Journal of Gynecological Cancer, vol.17, issue.1, pp.204-213, 2007.
DOI : 10.1111/j.1525-1438.2006.00751.x
, Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results, Journal of Cancer Research and Clinical Oncology, vol.28, issue.5, pp.1637-1682, 2009.
DOI : 10.1007/s00432-009-0667-4
, Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study, European Journal of Surgical Oncology (EJSO), vol.36, issue.6, pp.589-93, 2010.
DOI : 10.1016/j.ejso.2010.04.005
URL : https://hal.archives-ouvertes.fr/hal-00599226
, Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer, Journal of Surgical Oncology, vol.15, pp.149-55, 2010.
DOI : 10.1002/jso.21448
, Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence, Nature Reviews Clinical Oncology, vol.142, issue.2, pp.108-123, 2009.
DOI : 10.1038/nrclinonc.2009.217
, The tumor-promoting actions of TNF-?? involve TNFR1 and IL-17 in ovarian cancer in mice and humans, Journal of Clinical Investigation, vol.119, issue.10, pp.3011-3034, 2009.
DOI : 10.1172/JCI39065DS1
URL : https://hal.archives-ouvertes.fr/hal-00499385
, Niche-Dependent Tumorigenic Capacity of Malignant Ovarian Ascites-Derived Cancer Cell Subpopulations, Clinical Cancer Research, vol.15, issue.1, pp.70-80, 2009.
DOI : 10.1158/1078-0432.CCR-08-1233
, Study of T Lymphocytes Infiltrating Peritoneal Metastases in Advanced Ovarian Cancer, International Journal of Gynecological Cancer, vol.12, issue.8, pp.1329-1363, 2009.
DOI : 10.1111/IGC.0b013e3181b7a40e
, Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours, PLoS ONE, vol.171, issue.2, p.3894, 2008.
DOI : 10.1371/journal.pone.0003894.s002
, Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis, International Journal of Cancer, vol.16, pp.2090-101, 2010.
DOI : 10.1002/ijc.24886
, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nature Protocols, vol.99, issue.1, pp.44-57, 2008.
DOI : 10.1038/nprot.2008.211
, Database for annotation, visualization, and integrated discovery, Genome Biology, vol.4, issue.5, p.3, 2003.
DOI : 10.1186/gb-2003-4-5-p3
, Involvement of SDF-1??/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma, International Journal of Cancer, vol.276, issue.1, pp.91-99, 2008.
DOI : 10.1002/ijc.23083
, The cell of origin of ovarian epithelial tumours, The Lancet Oncology, vol.9, issue.12, pp.1191-97, 2008.
DOI : 10.1016/S1470-2045(08)70308-5
, Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers, Clinical & Experimental Metastasis, vol.2003, issue.22, pp.685-97, 2005.
DOI : 10.1007/s10585-004-5768-5
, Peritoneal and subperitoneal stroma may facilitate regional spread of ovarian cancer, Clin Cancer Res, vol.11, pp.113-135, 2005.
, Review, Studies in American Jewish Literature (1981-), vol.33, issue.2, pp.1198-211, 2005.
DOI : 10.5325/studamerjewilite.33.2.0268
, Multilineage Potential of Adult Human Mesenchymal Stem Cells, Science, vol.284, issue.5411, pp.143-190, 1999.
DOI : 10.1126/science.284.5411.143
, Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging, Stem Cells, vol.116, issue.10, pp.2614-2637, 2009.
DOI : 10.1002/stem.187
, Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells, Journal of Cellular Biochemistry, vol.80, issue.2, pp.499-510, 2008.
DOI : 10.1002/jcb.21641
, The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells, Proceedings of the National Academy of Sciences, vol.106, issue.10, pp.3806-3817, 2009.
DOI : 10.1073/pnas.0900244106
, Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line, Cancer, vol.46, issue.2, pp.311-334, 2009.
DOI : 10.1002/cncr.24032
, Cancer-Derived Lysophosphatidic Acid Stimulates Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells, Stem Cells, vol.25, issue.Pt 3, pp.789-97, 2008.
DOI : 10.1634/stemcells.2007-0742
, Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression, PLoS ONE, vol.72, issue.4, p.4992, 2009.
DOI : 10.1371/journal.pone.0004992.s004
, Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer, Cancer Res, vol.62, pp.5930-5968, 2002.
, CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers, Cancer Res, vol.65, pp.465-72, 2005.
, Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2, European Journal of Cancer Prevention, vol.16, issue.5, pp.430-465, 2007.
DOI : 10.1097/01.cej.0000236259.88146.a4
, The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells, Colloids and Surfaces B: Biointerfaces, vol.60, issue.1, pp.1-6, 2007.
DOI : 10.1016/j.colsurfb.2007.05.013
, A current review of targeted therapeutics for ovarian cancer
, Cancer Statistics, 2008, CA: A Cancer Journal for Clinicians, vol.58, issue.2, pp.71-96, 2008.
DOI : 10.3322/CA.2007.0010
, Cancer of the ovary, N Engl J Med, issue.24, pp.351-2519, 2004.
, Les cancers de l???ovaire : incidence et mortalit?? en France, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.34, issue.2, pp.154-61, 2005.
DOI : 10.1016/S0368-2315(05)82707-3
, Cancer incidence and mortality in France over the period 1980???2005, Revue d'??pid??miologie et de Sant?? Publique, vol.56, issue.3, pp.159-75, 2008.
DOI : 10.1016/j.respe.2008.03.117
URL : https://hal.archives-ouvertes.fr/hal-00538673
, ???Optimal??? cytoreduction for advanced epithelial ovarian cancer: A commentary, Gynecologic Oncology, vol.103, issue.1, pp.329-364, 2006.
DOI : 10.1016/j.ygyno.2006.07.004
, Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches, International Journal of Gynecological Cancer, vol.12, issue.6, pp.691-703, 2002.
DOI : 10.1046/j.1525-1438.2002.01152.x
, [Histologic study of the gonads in ovarian differentiation during organogenesis], Arch Anat Cytol Pathol, issue.6, pp.37-201, 1989.
, Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer, The Journal of Pathology, vol.59, issue.4, pp.451-457, 2001.
DOI : 10.1002/path.1000
, The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory, The American Journal of Surgical Pathology, vol.34, issue.3, pp.433-476
DOI : 10.1097/PAS.0b013e3181cf3d79
, Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study, European Journal of Surgical Oncology (EJSO), vol.36, issue.6, p.2010
DOI : 10.1016/j.ejso.2010.04.005
URL : https://hal.archives-ouvertes.fr/hal-00599226
, Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours, PLoS ONE, vol.171, issue.2, p.3894, 2008.
DOI : 10.1371/journal.pone.0003894.s002
, As Based upon Physiological and Pathological Histology, Nutrition Reviews, vol.47, issue.1, pp.23-25, 1989.
DOI : 10.1111/j.1753-4887.1989.tb02747.x
, THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST., The Lancet, vol.133, issue.3421, pp.1889-133
DOI : 10.1016/S0140-6736(00)49915-0
, Metastasis: guantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2'-deoxyuridine, J Natl Cancer Inst, vol.45, issue.4, pp.773-82, 1970.
, Role of Organ Selectivity in the Determination of Metastatic Patterns of B16 Melanoma, Cancer Research, issue.7, pp.40-2281, 1980.
, Mechanisms of Human Tumor Metastasis Studied in Patients with Peritoneovenous Shunts, Cancer Research, issue.8, pp.44-3584, 1984.
, Tumor Metastasis: Molecular Insights and Evolving Paradigms, Cell, vol.147, issue.2, pp.275-92, 2011.
DOI : 10.1016/j.cell.2011.09.024
, Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression, Nature Medicine, vol.23, issue.3, pp.320-329, 2011.
DOI : 10.1038/nm.2328
, Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium, Cancer Discovery, vol.1, issue.2, pp.144-147, 2011.
DOI : 10.1158/2159-8274.CD-11-0010
, Epithelial-Mesenchymal Transitions in Development and Disease, Cell, vol.139, issue.5, pp.871-90, 2009.
DOI : 10.1016/j.cell.2009.11.007
, Microenvironmental regulation of metastasis, Nature Reviews Cancer, vol.19, issue.4, pp.239-52, 2009.
DOI : 10.1038/nrc2618
, Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion, Cancer Research, vol.71, issue.7, pp.71-2455, 2011.
DOI : 10.1158/0008-5472.CAN-10-3323
URL : https://hal.archives-ouvertes.fr/inserm-00819288
, CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages, Cancer Cell, vol.16, issue.2, pp.91-102, 2009.
DOI : 10.1016/j.ccr.2009.06.018
, IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion, Genes & Development, vol.24, issue.3, pp.241-55, 2010.
DOI : 10.1101/gad.1874010
, Stromal gene expression predicts clinical outcome in breast cancer, Nature Medicine, vol.25, issue.5, pp.518-545, 2008.
DOI : 10.1038/nm1764
, The metastatic niche: adapting the foreign soil, Nature Reviews Cancer, vol.3, issue.4, pp.285-93, 2009.
DOI : 10.1038/nrc2621
, Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche, Cancer Cell, vol.15, issue.1, pp.35-44, 2009.
DOI : 10.1016/j.ccr.2008.11.012
, The First Line of Intra-abdominal Metastatic Attack: Breaching the Mesothelial Cell Layer, Cancer Discovery, vol.1, issue.2, pp.100-102, 2011.
DOI : 10.1158/2159-8290.CD-11-0117
, The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin, Journal of Clinical Investigation, vol.118, issue.4, pp.1367-79, 2008.
DOI : 10.1172/JCI33775
, Mesenchymal stem cells, J Orthop Res, issue.95, pp.641-50, 1991.
, Transplantation of Marrow to Extramedullary Sites, Science, vol.161, issue.3836, pp.161-54, 1968.
DOI : 10.1126/science.161.3836.54
, Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method, Exp Hematol, issue.2, pp.83-92, 1974.
, Osteogenic stem cells in bone marrow., in Bone and Mineral Research, pp.243-272, 1990.
, The mesengenic process, Clin Plast Surg, vol.21, issue.3, pp.429-464, 1994.
, Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues, Science, vol.276, issue.5309, pp.276-5309, 1997.
DOI : 10.1126/science.276.5309.71
, The Biology of Chemokines and their Receptors, Annual Review of Immunology, vol.18, issue.1
DOI : 10.1146/annurev.immunol.18.1.217
, Inflammation and cancer: back to Virchow? Lancet, pp.539-584, 2001.
, Chemokines in cancer, Cytokine & Growth Factor Reviews, vol.13, issue.2, pp.143-54, 2002.
DOI : 10.1016/S1359-6101(01)00033-8
, Breast tumor microenvironment: in the eye of the cytokine storm. Cell Cycle, pp.2420-2421
URL : https://hal.archives-ouvertes.fr/hal-01431948
, Stromal?derived factor?1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells, Nat Med, issue.712, pp.1339-1385, 2001.
, Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer, Cancer Res, issue.20, pp.62-5930, 2002.
, CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers, Cancer Res, vol.65, issue.2, pp.465-72, 2005.
, Up?regulation of CXCR4 expression in PC?3 cells by stromal?derived factor?1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway?dependent NF?kappaB activation, Cancer Res, issue.21, pp.65-9891, 2005.
, Akt activation, but not extracellular signal?regulated kinase activation, is required for SDF?1alpha/CXCR4?mediated migration of epitheloid carcinoma cells, Mol Cancer Res, vol.3, issue.4, pp.227-263, 2005.
, Cancer Stem Cells--Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells, Cancer Research, vol.66, issue.19, pp.66-9339, 2006.
DOI : 10.1158/0008-5472.CAN-06-3126
, Stem and progenitor?like cells contribute to the aggressive behavior of human epithelial ovarian cancer, Cancer Res, issue.8, pp.65-3025, 2005.
, Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors, Cancer Research, vol.68, issue.11, pp.68-4311, 2008.
DOI : 10.1158/0008-5472.CAN-08-0364
, Cancer Stem Cells and Aneuploid Populations within Developing Tumors Are the Major Determinants of Tumor Dormancy, Cancer Research, vol.69, issue.24
DOI : 10.1158/0008-5472.CAN-09-2802
, Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival, Cancer Research, vol.71, issue.11, pp.71-3991, 2011.
DOI : 10.1158/0008-5472.CAN-10-3175
URL : https://hal.archives-ouvertes.fr/hal-01431946
, Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells, International Journal of Cancer, vol.120, issue.Suppl 1, pp.29-39, 2012.
DOI : 10.1002/ijc.25967
, Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000.
DOI : 10.1038/35021093
, Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers, European Journal of Cancer, vol.38, issue.21, pp.346-1616, 2002.
DOI : 10.1016/S0959-8049(02)00269-1
, Gene Expression Signature With Independent Prognostic Significance in Epithelial Ovarian Cancer, Journal of Clinical Oncology, vol.22, issue.23, pp.22-4700, 2004.
DOI : 10.1200/JCO.2004.04.070
, Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy, Clinical Cancer Research, vol.11, issue.6, pp.2149-2155, 2005.
DOI : 10.1158/1078-0432.CCR-04-1673
, A biological question and a balanced (orthogonal) design: the ingredients to efficiently analyze two?color microarrays with Confirmatory Factor Analysis, BMC Genomics, issue.7, p.232, 2006.
, Molecular profiling of platinum resistant ovarian cancer, International Journal of Cancer, vol.22, issue.Suppl 8
DOI : 10.1002/ijc.21599
, An Integrated Genomic-Based Approach to Individualized Treatment of Patients With Advanced-Stage Ovarian Cancer, Journal of Clinical Oncology, vol.25, issue.5, pp.517-542, 2007.
DOI : 10.1200/JCO.2006.06.3743
, Integrated genomic analyses of ovarian carcinoma, Nature, vol.79, issue.7353, pp.474-609, 2011.
DOI : 10.1038/nature10166
, The clonal evolution of tumor cell populations, Science, vol.194, issue.4260, pp.791-798, 1976.
DOI : 10.1126/science.959840
, Evolutionary biology of cancer, Trends in Ecology & Evolution, vol.20, issue.10, pp.545-552, 2005.
DOI : 10.1016/j.tree.2005.07.007
, Metastasis: from dissemination to organ-specific colonization, Nature Reviews Cancer, vol.100, issue.4, pp.274-284, 2009.
DOI : 10.1038/nrc2622
, Clonal dominance of primary tumours by metastatic cells : genetic analysis and biological implications, Cancer Surv, vol.7, issue.4, pp.597-629, 1988.
, Metastasis genes: A progression puzzle, Nature, vol.418, issue.6900, pp.418-823, 2002.
DOI : 10.1038/418823a
, Chemotherapy in epithelial ovarian cancer, Cancer Letters, vol.303, issue.2, pp.73-83, 2011.
DOI : 10.1016/j.canlet.2011.01.026
, Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial, The Lancet, vol.376, issue.9737, pp.245-51
DOI : 10.1016/S0140-6736(10)60893-8
, Management of Platinum-Sensitive Recurrent Ovarian Cancer, Seminars in Oncology, vol.33, pp.12-16, 2006.
DOI : 10.1053/j.seminoncol.2006.03.012
, Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode, Nature, vol.3, issue.4972, pp.205-698, 1965.
DOI : 10.1038/205698a0
, Structure, Recognition, and Processing of Cisplatin???DNA Adducts, Chemical Reviews, vol.99, issue.9, pp.2467-2498, 1999.
DOI : 10.1021/cr980421n
, Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy., Journal of Clinical Investigation, vol.94, issue.2, pp.703-708, 1994.
DOI : 10.1172/JCI117388
, Metallothioneins and Platinum(II) Anti-Tumor Compounds, Current Medicinal Chemistry, vol.16, issue.5, p.16, 2009.
DOI : 10.2174/092986709787458452
, Kinetic study on the reaction of cisplatin with metallothionein. Drug Metabolism and Disposition, pp.31-916, 2003.
, Overexpressed human metallothionein IIA gene protects Chinese hamster ovary cells from killing by alkylating agents., Proceedings of the National Academy of Sciences, pp.2710-2714, 1990.
DOI : 10.1073/pnas.87.7.2710
, Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome, Virchows Archiv, vol.126, issue.3
DOI : 10.1007/s00428-006-0362-7
, Structure and function of glutathione S-transferases, BBA) ? Protein Structure and Molecular Enzymology, pp.1205-1206, 1994.
DOI : 10.1016/0167-4838(94)90086-8
, Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer, International Journal of Gynecological Cancer, vol.13, issue.6, pp.776-784, 2003.
DOI : 10.1111/j.1525-1438.2003.13381.x
, Expression of glutathione S-transferase pi (GST-pi) in human malignant ovarian tumors, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.96, issue.2, pp.202-208, 2001.
DOI : 10.1016/S0301-2115(00)00473-5
, Immunohistochemical analysis of drug resistance?associated proteins in ovarian carcinomas, Pathol Res Pract, issue.196, pp.469-475, 2000.
, The prognostic role of p53, metallothionein, P?glycoprotein, and MIB?1 in muscle?invasive urothelial transitional cell carcinoma, Clinical Cancer Research, issue.43, pp.559-565, 1998.
, Copper?transporting P?Type Adenosine Triphosphatase (ATP7B) Is Associated with Cisplatin Resistance, Cancer Research, vol.60, issue.5, pp.1312-1316, 2000.
, The Copper Export Pump ATP7B Modulates the Cellular Pharmacology of Carboplatin in Ovarian Carcinoma Cells, Molecular Pharmacology, vol.64, issue.2, pp.466-473, 2003.
DOI : 10.1124/mol.64.2.466
, Prognostic Value of the Cu-Transporting ATPase in Ovarian Carcinoma Patients Receiving Cisplatin-Based Chemotherapy, Clinical Cancer Research, vol.10, issue.8, pp.10-2804, 2004.
DOI : 10.1158/1078-0432.CCR-03-0454
, Copper?transporting P?type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma. Cancer letters, pp.33-38, 2003.
, Copper-transporting P-Type Adenosine Triphosphatase (ATP7B) Is Expressed in Human Breast Carcinoma, Japanese Journal of Cancer Research, vol.325, issue.Suppl, pp.93-70, 2002.
DOI : 10.1111/j.1349-7006.2002.tb01202.x
, The complexity of p53 modulation: emerging patterns from divergent signals, Genes & Development, vol.12, issue.19, pp.12-2973, 1998.
DOI : 10.1101/gad.12.19.2973
, Apoptosis - the p53 network, Journal of Cell Science, vol.116, issue.20, pp.4077-4085, 2003.
DOI : 10.1242/jcs.00739
, p53 in apoptosis control: An introduction, Biochemical and Biophysical Research Communications, vol.331, issue.3, pp.685-687, 2005.
DOI : 10.1016/j.bbrc.2005.04.013
, TP53 and ovarian cancer, Human Mutation, vol.16, issue.3, pp.285-291, 2003.
DOI : 10.1002/humu.10181
, Chemoresistance in human ovarian cancer: the role of apoptotic regulators, Reproductive Biology and Endocrinology, vol.1, issue.1, p.66, 2003.
DOI : 10.1186/1477-7827-1-66
, Inhibition of Inhibitor of Nuclear Factor?OE ? B Phosphorylation Increases the Efficacy of Paclitaxel in in Vitro and in Vivo Ovarian Cancer Models, Clinical Cancer Research, issue.22, pp.10-7645, 2004.
, Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells, Journal of Biological Chemistry, vol.278, issue.21, p.278, 2003.
DOI : 10.1074/jbc.M208134200
, Identification of Genes That Mediate Sensitivity to Cisplatin, Molecular Pharmacology, vol.60, issue.6, pp.1153-1160, 2001.
, Mitotic Block Induced in HeLa Cells by Low Concentrations of Paclitaxel (Taxol) Results in Abnormal Mitotic Exit and Apoptotic Cell Death, Cancer Research, vol.56, issue.4, pp.816-825, 1996.
, Taxol stabilizes microtubules in mouse fibroblast cells., Proceedings of the National Academy of Sciences, vol.77, issue.3, pp.1561-1565, 1981.
DOI : 10.1073/pnas.77.3.1561
, Paclitaxel (Taxol), New England Journal of Medicine, issue.15, pp.332-1004, 1995.
, The binding conformation of Taxol in OE??tubulin: A model based on electron crystallographic density, Proceedings of the National Academy of Sciences, pp.98-5312, 2001.
, Decreased Expression of Intelectin 1 in the Human Airway Epithelium of Smokers Compared to Nonsmokers, The Journal of Immunology, vol.181, issue.8, pp.181-5760, 2008.
DOI : 10.4049/jimmunol.181.8.5760
, Cloning and expression of murine sister of P? glycoprotein reveals a more discriminating transporter than MDR1/P? glycoprotein, Mol Pharmacol, vol.57, issue.1, pp.24-35, 2000.
, MULTIDRUG RESISTANCE IN CANCER: ROLE OF ATP-DEPENDENT TRANSPORTERS, Nature Reviews Cancer, vol.2, issue.1, pp.48-58, 2002.
DOI : 10.1038/nrc706
, Analysis of the Drug Resistance Profile of Multidrug Resistance Protein 7 (ABCC10): Resistance to Docetaxel, Cancer Research, vol.64, issue.14, pp.64-4927, 2004.
DOI : 10.1158/0008-5472.CAN-03-3111
, Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours, Cancer Chemotherapy and Pharmacology, vol.28, issue.9, pp.154-60, 2005.
DOI : 10.1007/s00280-004-0942-7
, Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublinesin vitro, Investigational New Drugs, vol.47, issue.Supplement 3, pp.169-82, 1994.
DOI : 10.1007/BF00873957
, Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein, European Journal of Cancer, vol.40, issue.8, pp.40-1269, 2004.
DOI : 10.1016/j.ejca.2004.01.024
, beta?Tubulin mutations are associated with resistance to 2?methoxyestradiol in MDA?MB?435 cancer cells, Cancer Res, issue.20, pp.65-9406, 2005.
, Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of ??-tubulin (Asp26Glu) and less stable microtubules, Molecular Cancer Therapeutics, vol.5, issue.2, pp.270-278, 2006.
DOI : 10.1158/1535-7163.MCT-05-0190
, Alterations of beta?tubulin isotypes in breast cancer cells resistant to docetaxel, FASEB J, vol.19, issue.10, pp.1299-301, 2005.
, Changes in Microtubule Protofilament Number Induced by Taxol Binding to an Easily Accessible Site. INTERNAL MICROTUBULE DYNAMICS, Journal of Biological Chemistry, vol.273, issue.50, pp.273-33803, 1998.
DOI : 10.1074/jbc.273.50.33803
, Conservation of the class I beta?tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel?resistant ovarian cancers, Mol Cancer Ther, vol.1, issue.3, pp.215-240, 2002.
, DJ-927, a novel oral taxane, overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo, Cancer Science, vol.40, issue.5, pp.94-459, 2003.
DOI : 10.1038/87912
, Drug evaluation: tesetaxel??an oral semisynthetic taxane derivative, Curr Opin Investig Drugs, issue.712, pp.1092-1101, 2006.
, Environment-mediated drug resistance: a major contributor to minimal residual disease, Nature Reviews Cancer, vol.112, issue.9, pp.665-74, 2009.
DOI : 10.1038/nrc2714
, Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo, Science, vol.247, issue.4949, pp.1457-61, 1990.
DOI : 10.1126/science.2108497
, Modeling Tissue Morphogenesis and Cancer in 3D, Cell, vol.130, issue.4, pp.601-611, 2007.
DOI : 10.1016/j.cell.2007.08.006
, Gene expression perturbation in vitro???A growing case for three-dimensional (3D) culture systems, Seminars in Cancer Biology, vol.15, issue.5, pp.405-417, 2005.
DOI : 10.1016/j.semcancer.2005.06.009
, Cell interactions with three-dimensional matrices, Current Opinion in Cell Biology, vol.14, issue.5, pp.633-642, 2002.
DOI : 10.1016/S0955-0674(02)00364-2
, Taking Cell-Matrix Adhesions to the Third Dimension, Science, vol.294, issue.5547, pp.1708-1720, 2001.
DOI : 10.1126/science.1064829
, Capturing complex 3D tissue physiology in vitro, Nature Reviews Molecular Cell Biology, vol.263, issue.3, pp.211-235, 2006.
DOI : 10.1038/nrm1858
, Of Extracellular Matrix, Scaffolds, and Signaling: Tissue Architecture Regulates Development, Homeostasis, and Cancer, Annual Review of Cell and Developmental Biology, vol.22, issue.1, pp.287-309, 2006.
DOI : 10.1146/annurev.cellbio.22.010305.104315
, Fibroblast biology in three-dimensional collagen matrices, Trends in Cell Biology, vol.13, issue.5, pp.264-273, 2003.
DOI : 10.1016/S0962-8924(03)00057-6
, Modification of gene expression of the small airway epithelium in response to cigarette smoking, Journal of Molecular Medicine, vol.89, issue.1, pp.39-53, 2007.
DOI : 10.1007/s00109-006-0103-z
, Mesenchymal Cell Interaction with Ovarian Cancer Cells Triggers Pro-Metastatic Properties, PLoS ONE, vol.474, issue.5, p.38340, 2012.
DOI : 10.1371/journal.pone.0038340.s002
, Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment, The Lancet Oncology, vol.10, issue.1, pp.72-79, 2009.
DOI : 10.1016/S1470-2045(08)70335-8
, Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis, Nature Cell Biology, vol.17, issue.12, pp.1369-1375, 2006.
DOI : 10.1016/S0092-8674(00)80108-7
, Preparing the "Soil": The Premetastatic Niche, Cancer Research, vol.66, issue.23, pp.66-11089, 2006.
DOI : 10.1158/0008-5472.CAN-06-2407
, Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses, International Journal of Cancer, vol.13, issue.9, pp.2143-2152, 2010.
DOI : 10.1002/ijc.24881
, Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis, International Journal of Cancer, vol.16, issue.9, pp.2090-2101, 2010.
DOI : 10.1002/ijc.24886
, Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts, Clinical & Experimental Metastasis, vol.75, issue.3, pp.26-993, 2009.
DOI : 10.1007/s10585-009-9289-0
, Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In, Vivo Bioluminescent Imaging. STEM CELLS, issue.10, pp.27-2614, 2009.
, Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial???mesenchymal transition in ovarian carcinomas, British Journal of Cancer, vol.131, issue.5, pp.134-178, 2009.
DOI : 10.1242/jcs.005298
, Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast, Cell, vol.145, issue.6, pp.926-966, 2011.
DOI : 10.1016/j.cell.2011.04.029
, Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer, pp.79-884, 1997.
, Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity, International Journal of Gynecological Cancer, vol.17, issue.1, pp.204-209, 2007.
DOI : 10.1111/j.1525-1438.2006.00751.x
, Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results, Journal of Cancer Research and Clinical Oncology, vol.28, issue.5, pp.135-1637, 2009.
DOI : 10.1007/s00432-009-0667-4
, Niche-Dependent Tumorigenic Capacity of Malignant Ovarian Ascites-Derived Cancer Cell Subpopulations, Clinical Cancer Research, vol.15, issue.1, pp.70-80, 2009.
DOI : 10.1158/1078-0432.CCR-08-1233
, Study of T Lymphocytes Infiltrating Peritoneal Metastases in Advanced Ovarian Cancer, International Journal of Gynecological Cancer, vol.12, issue.8, 2009.
DOI : 10.1111/IGC.0b013e3181b7a40e
, Hyperthermia?treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line. Cancer, pp.311-323, 2009.
, Jagged-1 and Notch3 Juxtacrine Loop Regulates Ovarian Tumor Growth and Adhesion, Cancer Research, vol.68, issue.14, pp.68-5716, 2008.
DOI : 10.1158/0008-5472.CAN-08-0001
, Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids, Cancer Cell, vol.20, issue.3, pp.370-383, 2011.
DOI : 10.1016/j.ccr.2011.08.010
, Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth, Nature Medicine, vol.239, issue.11, pp.17-1498, 2011.
DOI : 10.1007/s12014-010-9055-y
, Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer, Current Pharmaceutical Design, vol.18, issue.25, pp.18-3816, 2012.
DOI : 10.2174/138161212802002797
, Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance, Journal of Cellular Biochemistry, vol.7, issue.1, 2012.
DOI : 10.1002/jcb.24317